• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/44

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

44 Cards in this Set

  • Front
  • Back
in tet-on system, to find reporgramming duration, yamanaka factors expressed when___(part of tetoracycline antibotics) added to culture
doxycycline
When the factors were expressed for less than 10 days_____. At least_____days of factor expression were
necessary to derive iPSCs.
no iPSCs emerged
12
after 14-16 days iPSCs colonies could
grow without doxycycline
this duration (2weeks) coincides with expression of endogenous oct4/nanog
do factors need to be integrated permenantley into genome
no, we can treat cells temporarily
-Some iPSC lines carry epigenetic marks typical to the
-due to this, not all iPSCs may be
cell lineage of their origin
equivalent
*they show epigenetic memory
other than the epigenetic memory of iPSC these cells are entirely compatible with ___by most criteria
and show reprogramming can be used to establish the esc ___
esc
phenotype
iPSCs present a great promise to generate______ pluripotent stem cell lines.
patient-specific
reprogramming is__process
gradual
dna methylation/histone modification affected by
cells of origin
experimental manipulations difficult and highly inaccessible because
all developmental processes in mammals occur in utero
if we can direct ESCs to differentiate into a specific lineage at our will, then, we should be able to
produce target cells for cell replacement therapy
induction of directed differentiation in pluripotent stem cells is the essential step for
clinical applications of ESCs
can u use esc's/ipsc's for analyzing drug effects
yes
so induction of directed esc diff important but hard to do because
proportion of cells made and absolute numbers are small
type 1 diabetes due to
loss of insulin secreting cells
can possibly use esc/ipsc's replacemnt therapy
pancrease derived from___
pancreatic buds induced on__(2() sides of gut
develops from
has both (2) function
islets make___
endoderm
dorsal and ventral
embryonic gut
endo/exocrine
endocrine hormones
alpha cells (20%) make
beta cells (50%) make
delta (5%) make
glucagon
insulin
somatostain
*endocrine hormones
acini secrete
digetsive enzymes (exocrine)
During the pancreatic development, a series of transcription factors are expressed sequentially in a
_____manner
timely
in pancreas development (Shh) is expressed in definitive endoderm but its expression____as pancreas specified
Pdx1 is
declines
upregulated
delete pdx1=
no pancreas
Although Pdx1 is initially expressed only
temporarily at the time of pancreatic specification (~embryonic day 10), the gene is expressed again
later when
pancreatic b-cells emerge
pdx1 is ___TF
homeodomain
pax4 is homedomain TF that induces
beta cells
stz (streoptozotocin)
kills beta cells
transplanting beta cells derived from esc leads to
reduced blood glucose
*implies beta cells from esc are functional
**this is proof of principle study for directed diff induced in esc's
next slides looking at beta induction using GF's
..
since ESC's similar to ICM gastrulation like responses need to be induced, this done by(2)
NODAL AND WNT
nodal is part of___family
TGFbeta
cells destined to become endoderm located
near _____at the primitive-streak stage. It secretes a growth factor, called___. High level of that promotes differentiation into the _____, low level stimulates differentiation into the ____.
node
“nodal”
endoderm
mesoderm
*ie location of cells, level of nodal, and endodermal differentiation seems to correlate each other
activin (TGFbeta family GF) can mimic___in vitro
nodal
patterns of Shh expression in endoderm correlate with
proximity of notochord
*shh exp in dorsal endo suppressed by notochord
shh expressed in notochord/ventral endo
(2) factors in notochord are what suppress shh in dorsal endo
activin, FGF2
when activin is added to in vitro culture of the isolate gut, dose dependent induction of _____and ____is seen
Pdx1 , insulin
low dose of FGF2=
medium=
high=
pdx1 exp
insulin exp
reduce pdx1/insulin
effect of activin suppressed by
shh
neutralizing antibodies+shh=
genes for pancreas development induced ie shh expression needs to be inhibited for pancreas development to happen
notochord is__organ
mesodermal
singals between endoderm and mesoderm control (2) of pancreas
identity and patterning
researchers made 5step protocol for pancreatic induction from hESC. step 5 when generate mature insulin secreting beta cell in vitro BUT they got rid of step 5 why?
-completing all diff processes made no sense
-had limited number of beta cells in vitro
-end of culture esc derived cells expressed pancreas genes and initiated endocrine lineage *didnt mature enough to make insulin/glucagon
implanted human pancreas (embryonic) under kidney of mouse. before implanted had few cells stained by antiinsulin/glucagon antibodies-->confirms that
-after 2 months of implant saw
-after 21 weeks____cells seen
*results show that human beta cells can develop
-embryonic pancreas had developed in donor BUT endocrine had not
-increase growth (200X weight, 5000x # beta cells)
-insulin expressing
*spont from immature pancreas
primitive pancreatic cells divide and prolif but once they commit to diff into the____lineage they do not prolif or prolif much less
endocrine cell
*pdx1(more primitive) incorp BrdU and ngn(more committed to endocrine lineage) dont
to verify that have pancreatic cells you:
measure level of __in blood
inject___at dose that kills mice beta more selectively than human beta cells
found that __level didnt change after injection suggest human___effective in absence of mouse counterpart
if remove implanted ESC derived pancreas cells glucose levels___
insulin
STZ
glucose
insulin
overshot
4 practical issues about 5step
effciency
tumorigenicity
transplantion site
complexity